Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
481 to 500 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| F31GM134649 | A Budding Yeast Model for Human Disease-Mutations in the RNA Exosome | 1 | 2022 |
| F31HL154665 | Improving cardiovascular disease modeling using human pluripotent stem cell-derived cardiac fibroblasts | 1 | 2022 |
| I01BX000333 | Potential of Hematopoietic Stem Cell-Based Therapies for Complicated Fractures | 1 | 2022 |
| IK2CX001953 | Improving Treatment Algorithms for Veterans with Oropharyngeal Cancer | 1 | 2022 |
| K01AR072132 | Dissect stress response in skin epithelial wounding and hyperproliferative disorders | 1 | 2022 |
| K08CA222676 | Functional Proteomic Analysis and Biomarker Identification in a Novel Mouse Model of Metastatic Hepatocellular Carcinoma (HCC) | 1 | 2022 |
| K12CA157688 | MUSC/HCC Paul Calabresi Clinical Oncology Career Development Program | 1 | 2022 |
| OT3HL142478 | The Integration of Trans-omics for Precision Medicine (TOPMED) and Other Heart, Lung, Blood and Sleep (HLBS) Data Sets with the Data Commons | 1 | 2022 |
| OT3HL142480 | The Integration of Trans-omics for Precision Medicine (TOPMED) and Other Heart, Lung, Blood and Sleep (HLBS) Data Sets with the Data Commons | 1 | 2022 |
| P01CA221757 | Modeling bladder cancer pathogenesis and tumor evolution | 1 | 2022 |
| P20GM103639 | Mentoring Translational Cancer Research in Oklahoma | 1 | 2022 |
| P20GM104357 | Cardiorenal and Metabolic Diseases Research Center | 1 | 2022 |
| P42ES010337 | Harnessing Technological Innovation and Community-Engaged Implementation Science to Optimize COVID-19 Testing for Women and Children in Underserved Communities | 1 | 2022 |
| R01AG015768 | Viscoelastic Properties of Normal and OA Chondrons | 1 | 2022 |
| R01AG057598 | Development of Attenuated Furoxans as Novel Therapies for Alzheimer's Disease | 1 | 2022 |
| R01AG059635 | Understanding the role of mitochondrial UPR-activating mtDNA landscapes in health and longevity. | 1 | 2022 |
| R01AR072597 | Pathologic Role of Inflammation and Mechanistic Analysis of Myofibroblastogenesis in Arthrofibrosis | 1 | 2022 |
| R01CA116020 | Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma | 1 | 2022 |
| R01CA155243 | Pleiotropic functions of FOXC2 in EMT, stem cells and breast cancer progression | 1 | 2022 |
| R01CA208236 | MR Fingerprinting and Computerized Decision Support for Prostate Cancer | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=25